AP2005003294A0 - Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome - Google Patents

Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome

Info

Publication number
AP2005003294A0
AP2005003294A0 AP2005003294A AP2005003294A AP2005003294A0 AP 2005003294 A0 AP2005003294 A0 AP 2005003294A0 AP 2005003294 A AP2005003294 A AP 2005003294A AP 2005003294 A AP2005003294 A AP 2005003294A AP 2005003294 A0 AP2005003294 A0 AP 2005003294A0
Authority
AP
ARIPO
Prior art keywords
prevention
treatment
acquired immunodeficiency
immunodeficiency syndrome
synergistic compositions
Prior art date
Application number
AP2005003294A
Other languages
English (en)
Inventor
Sek Fung Fung
Original Assignee
Tanox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanox Inc filed Critical Tanox Inc
Publication of AP2005003294A0 publication Critical patent/AP2005003294A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AP2005003294A 2002-09-27 2003-09-26 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome AP2005003294A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41406202P 2002-09-27 2002-09-27
PCT/US2003/030538 WO2004028473A2 (en) 2002-09-27 2003-09-26 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome

Publications (1)

Publication Number Publication Date
AP2005003294A0 true AP2005003294A0 (en) 2005-06-30

Family

ID=32043337

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2005003294A AP2005003294A0 (en) 2002-09-27 2003-09-26 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome

Country Status (12)

Country Link
US (1) US20060121480A1 (xx)
EP (1) EP1543166A4 (xx)
JP (1) JP2006503849A (xx)
CN (3) CN101152574A (xx)
AP (1) AP2005003294A0 (xx)
AU (1) AU2003299085B2 (xx)
BR (1) BR0314711A (xx)
CA (1) CA2498483A1 (xx)
HK (1) HK1082923A1 (xx)
MX (1) MXPA05002851A (xx)
WO (1) WO2004028473A2 (xx)
ZA (1) ZA200502464B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60229677D1 (de) 2001-05-31 2008-12-11 Conjuchem Biotechnologies Inc Langwirkende Fusionspeptidinhibitoren gegen HIV-Infektion
US20080039532A1 (en) * 2004-05-06 2008-02-14 Dominique Bridon Compounds For Specific Viral Target
BRPI0715794A2 (pt) * 2006-08-17 2013-07-23 Hoffmann La Roche conjugado de anticorpo contra ccr5 e peptÍdeo antifusogÊnico
TW200817438A (en) * 2006-08-17 2008-04-16 Hoffmann La Roche A conjugate of an antibody against CCR5 and an antifusogenic peptide
CL2008002092A1 (es) * 2007-07-20 2009-05-29 Hoffmann La Roche Conjugado que contiene dos o mas peptidos antifusogenicos y un anticuerpo anti-cd-4; metodo de produccion; composicion farmaceutica que lo comprende; polipeptidos antifusogenicos y uso del conjugado para tratar infecciones viricas.
RU2517084C2 (ru) * 2010-08-06 2014-05-27 Олег Ильич Эпштейн Способ и средство для ингибирования продукции или усиления элиминации белка р24
CN106139150B (zh) * 2015-04-10 2019-10-08 复旦大学 一种艾滋病治疗性疫苗组合物及其应用
PT3286212T (pt) * 2015-04-24 2021-08-24 Viiv Healthcare Uk No 5 Ltd Polipéptidos dirigidos para fusão com hiv

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2094713A1 (en) * 1990-10-26 1992-04-27 Shermaine A. Tilley Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120
DE69126301T2 (de) * 1990-11-27 1998-01-02 Biogen, Inc., Cambridge, Mass. Hiv-induzierte synzytien blockierender anti-cd-4-antikörper
US6136310A (en) * 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
US5397703A (en) * 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
US5817767A (en) * 1993-02-24 1998-10-06 Progenics Pharmaceuticals, Inc. Synergistic composition of CD4-based protein and anti-HIV-1 antibody, and methods of using same
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
KR100571215B1 (ko) * 1995-06-07 2006-10-24 트라이머리스 인코퍼레이티드 복합적인치료요법을이용한hiv와다른바이러스감염의치료
US7122185B2 (en) * 2002-02-22 2006-10-17 Progenics Pharmaceuticals, Inc. Anti-CCR5 antibody

Also Published As

Publication number Publication date
ZA200502464B (en) 2005-11-01
CA2498483A1 (en) 2004-04-08
HK1082923A1 (en) 2006-06-23
AU2003299085B2 (en) 2008-04-10
CN101152573A (zh) 2008-04-02
WO2004028473A3 (en) 2004-12-09
BR0314711A (pt) 2005-07-26
MXPA05002851A (es) 2005-09-08
CN1685064A (zh) 2005-10-19
WO2004028473A2 (en) 2004-04-08
JP2006503849A (ja) 2006-02-02
US20060121480A1 (en) 2006-06-08
EP1543166A2 (en) 2005-06-22
AU2003299085A1 (en) 2004-04-19
CN101152574A (zh) 2008-04-02
CN100341573C (zh) 2007-10-10
EP1543166A4 (en) 2009-10-28

Similar Documents

Publication Publication Date Title
HK1152474A1 (en) Methods and compositions for the prevention and treatment of sepsis
AU2003205737A1 (en) Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
EP1753777A4 (en) METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING HIV INFECTION WITH TRIM5a
IL162838A0 (en) Compositions and methods for prevention and treatment peptide-of amyloid- related disorders
ZA200110504B (en) Dietary or pharmaceutical compositions for use for the prevention or treatment of hyperoxaluria.
EP1578437A4 (en) COMPOSITIONS AND METHODS FOR PREVENTING AND REDUCING INSULIN-INDUCED HYPOGLYCEMIA
IL158181A0 (en) N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
EG23626A (en) Synergistic seed treatment compositions
EP1476471A4 (en) FUNCTIONAL FOODS FOR THE TREATMENT, PROTECTION AND RESTORATION OF CONNECTIVE TISSUES
HK1082923A1 (en) Synergistic compositions for the prevention and treatment of acquired immunodeficiency
AU2003291480A8 (en) Composition for the prevention and treatment of inflammation of the ear
AU2003211610A1 (en) Pharmaceutical compositions for the treatment or prevention of osteoporosis
HUP0300990D0 (en) Synergistic combination for the prophylaxis and treatment of diabetes
IL161091A0 (en) Compositions for the treatment and prevention of plant pathogens
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
YU11904A (sh) Upotreba inhibitora il-18 kod poremećaja preosetljivosti
EP1305017A4 (en) METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF SYNDROME X
MXPA03006468A (es) Composiciones para la prevencion o tratamiento de hepatopatia.
AU2003291461A8 (en) Compositions for diabetes treatment and prophylaxis
EP1660007A4 (en) COMPOSITIONS FOR THE TREATMENT AND PROPHYLAXIS OF DIABETES
IL151658A0 (en) Methods and compositions for the treatment or prevention of cardiovascular diseases
AU2003301170A8 (en) Compositions for the treatment and prevention of nephropathy
SI1408966T1 (sl) Sinergistične farmacevtske kombinacije za preprečevanje ali zdravljenje diabetesa
EP1581246A4 (en) COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF NEPHROPATHY
SI1569929T1 (sl) Spojine in postopki za zdravljenje ali preprečevanje flavivirusnih infekcij